Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study

Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study

<p>Abstract</p> <p>Background</p> <p>Crohn's disease (CD) and multiple sclerosis (MS) share common pathogenic processes. Interferon (IFN) beta-1a is effective and generally well tolerated in patients with MS and has been shown to down-regulate the expression of int...

Full description

Bibliographic Details
Main Authors: Hunter John O, Tomasevic Ratko, Hanauer Stephen B, Pena Rossi Claudia, Shafran Ira, Graffner Hans
Format: Article
Language:English
Published: BMC 2009-03-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/9/22

Similar Items

Similar Items